Historical record - last NADAC effective date: 7/17/2024
Product Information
ROPINIROLE HCL 1 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0515 per EA under NDC 16729023401. Its NADAC has been published 301 times since Nov 14, 2018.
FDA first approved this application on Feb 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729023401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204022FDA Approved
2/28/2017
TE Code
AB
On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 1 MG TABLET has been published 301 times since Nov 14, 2018, and over the history we have for it it has declined 12.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0515 per EA |
|---|---|
| All-time high | $0.0614 (Feb 10, 2021) |
| All-time low | $0.0460 (Apr 17, 2024) |
| Median price | $0.0569 |
| Average price | $0.0559 |
| Largest weekly change | -18.6% (Apr 17, 2024) |
| Weeks tracked | 301 |
| Tracking since | Nov 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-10.1%
5Y
-4.2%
All
-12.7%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 1 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0515 per EA (NDC 16729023401), effective Aug 14, 2024.
How has the price of ROPINIROLE HCL 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 1 MG TABLET has declined 12.7%. It has been tracked across 301 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 1 MG TABLET?
Since Nov 14, 2018, the NADAC for ROPINIROLE HCL 1 MG TABLET has ranged from a low of $0.0460 (Apr 17, 2024) to a high of $0.0614 (Feb 10, 2021), with a median of $0.0569 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 1 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROPINIROLE HCL 1 MG TABLET, is $0.0488 per EA — about 5% below ROPINIROLE HCL 1 MG TABLET.
Who manufactures ROPINIROLE HCL 1 MG TABLET?
ROPINIROLE HCL 1 MG TABLET (NDC 16729023401) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.